IGFBP3 and melanoma: There is also evidence of IGFBP-3 being associated with metastatic disease, with IGFBP-3 expression elevated in metastatic tissue compared with primary tumor in melanoma [24], and higher in metastatic than nonmetastatic tumors in pancreatic endocrine neoplasms [25].